Products and services

Products and services

Lingsu® Quetiapine Fumarate Sustained-Release Tablets

Indication:This product is used for the treatment of depressive episodes in schizophrenia and bipolar disorder.

Strength:200mg: 60 tablets/bottle, 20 tablets/bottle, 21 tablets/bottle, 30 tablets/bottle.

Package:Oral solid medicine in high-density polyethylene bottle; 150mg: 60 tablets/bottle, 20 tablets/bottle, 21 tablets/bottle, 30 tablets/bottle.

Validity:24 months

Approval number:150mg: National Medicine Standard H20203235
                 200mg: National Medicine Standard H20203236

- Continuous drug release once a day to improve compliance;

- Rapid titration, quickly reach the effective therapeutic dose;

- Lower incidence of adverse reactions such as sedation and no weight gain;

- Control acute symptoms of schizophrenia, stabilize long-term symptoms and reduce the risk of relapse; recommendation for acute episodes of bipolar depression, mania and maintenance treatment.

Fax:

微信公众号